With the effective prevention and control of COVID - 19 in China the number of cured cases increased significantly. Further monitoring of the disease prognosis and effective control of the "relapse" of the epidemic become the next focus of work. To analyse the clinical prognosis of discharged COVID-19 patients by monitoring their SAR-CoV-2 nucleic acid status which may provide evidence to establish discharge standards and follow-up management for COVID-19 patients. Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu China.